Early diagnosis matters: Lung cancer screening saves lives

Early screening is the key to helping clinicians diagnose lung cancer early and AI-streamlined radiology workflows can help.
By

Lung cancer is the leading cause of cancer deaths for both men and women in the United States, killing more than 150,000 people annually. Lung cancer accounts for even more deaths than breast, prostate and colon cancer combined, according to the American Cancer Society.  An even more sobering statistic comes from the Lung Cancer Alliance:  an estimated 1 in 15 Americans will be diagnosed with lung cancer at some point in their lives.

This month we acknowledge National Lung Cancer Awareness Month as well as the clinicians, patients and families affected by lung cancer.  The message emerging from oncology experts in recent years is loud and clear: Early screening is the key to helping clinicians diagnose lung cancer early.

A strong lung cancer screening (LCS) program requires clinicians to capture more than 50 pieces of data per visit and monitor patients closely, including follow-up scans, each with many more data points to capture.

Starting with the first imaging event, patients benefit from a highly coordinated approach that involves frequent tracking, patient reminders and data capturing.

Screening awareness received a major boost in 2015 when CMS began to cover lung cancer screening protocols with low dose computed tomography, if certain eligibility requirements were met. Great strides in screening technology have been made since then, said Andrea McKee, MD, a radiation oncologist for Lahey Hospital and Medical Center, one of the industry’s earliest partners in developing LCS tools.

Lahey has seen its Stage I diagnoses rise to 69% (compared to the national average of 25%) and has reduced the number of screened patients diagnosed with Stage IV from 35% to less than 10%. “This shift from late to early stages has tremendous implications for survival rate and patient care overall,” said Dr. McKee.

Our goal is to deliver the most efficient and accurate tools for lung cancer screening, which will in turn give care providers the potential to reach more patients and to save more lives.

Join us at the upcoming Radiological Society of North America (RSNA) meeting later this month. Schedule an appointment with us here and visit our team in booth #2700. 

Follow us on LinkedIn and Twitter to learn more.

Tags:

  • Cancer Treatment

    Hello! I found you article informative. But aside from lung cancer, is there any screening that can be done to colon cancer patients to help clinicians diagnose early before it becomes worst?

  • Cancer Treatment

    Hi! This is a great news! Lung cancer screening indeed help clinicians diagnosed lung cancer early and it will prevent the cancer from spreading through the body. In an article about lung cancer https://www.cancertreatment.education/lung-cancer-survival-rates-prognosis/ ive read an indication of survival among patients and stressed on prognosis which depends upon the its stages

Karen Holzberger

About Karen Holzberger

Karen Holzberger is the vice president and general manager of Nuance’s Healthcare’s diagnostic solutions business. Karen joined Nuance in 2014 with more than 15 years of experience in the Healthcare industry. Prior to Nuance, she was the vice president and general manager of Global Radiology Workflow at GE Healthcare where she managed service, implementation, product management and development for mission critical healthcare IT software. Karen attended Stevens Institute of Technology where she earned a B.S in Mechanical Engineering.